Small Pharma

Small Pharma

Pipeline of novel patent-protected deuterium-enriched tryptamine compounds for psychedelic-assisted psychotherapy as a rapid onset, sustained treatment for mental health disorders.

HQ location
London, United Kingdom
Website
smallpharma.com
Launch date
Employees
11-50 people
Market cap
$36.9m
Enterprise value
$28m
Share price
CAD0.15 DMT.V
Company register number
09420724
https://twitter.com/smallpharmahttps://www.linkedin.com/company/small-pharma-inc/
    • Edit
loading funding rounds…
ACF Investors
ACF Investors(exited)
O2h Ventures
O2h Ventures(exited)
Cybin
Cybin
Small Pharma (Formerly Unilock Capital Corp)
Small Pharma (Formerly Unilock Capital Corp)(exited)
re.Mind Capital
re.Mind Capital(exited)
Ambria Capital
Ambria Capital(exited)
Adrian Rands
Adrian Rands(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2020202120222023
Revenues0000000000000000
% growth-4 %--
EBITDA0000000000000000
% EBITDA margin(8000 %)(7232 %)--
Profit0000000000000000
% profit margin-(9061 %)--
EV0000000000000000
EV / revenue00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x
R&D budget0000000000000000
R&D % of revenue-2473 %--

Source: Company filings or news article

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo